Products
Online Inquiry
2,4-Diamino-6-hydroxypyrimidine
Cat. No.:
0225LY-1156
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, and LC-MS.
Size:
Add to basket
Product Overview
Description:
2,4-Diamino-6-hydroxypyrimidine (DAHP) functions as a specific and selective inhibitor of GTP cyclohydrolase I, which is the primary rate-limiting enzyme in the de novo synthesis of pterins.
Synonym:
DAHP; 56-06-4; 2,6-diaminopyrimidin-4-ol; 2,6-diaminopyrimidin-4(3H)-one; 2,6-Diaminopyrimidin-4(1H)-one; 143504-99-8; 4(1H)-Pyrimidinone, 2,6-diamino-; 2,6-Diamino-4-hydroxypyrimidine; 2,6-Diamino-1H-pyrimidin-4-one; 2,6-Diamino-4-pyrimidinol; 2,6-Diamino-4-pyrimidinone; 2,6-diamino-3,4-dihydropyrimidin-4-one; 4-Pyrimidinol, 2,6-diamino-; 4(3H)-pyrimidinone, 2,6-diamino-; 2,4-diamino-1H-pyrimidin-6-one; 2,6-Diamino-4(1H)-pyrimidinone; 2,4-Diamino-6-pyrimidinone; 2,6-Diaminopyrimidin-4-one; 2-Aminoisocytosine; 6-Aminoisocytosine; 2,6-Diamino-3H-pyrimidin-4-one; 2,6-Diamino-4(3H)-pyrimidinone
CAS No.:
56-06-4
Compound CID:
135408763
Formula:
C4H6N4
Formula Weight:
126.12
Specification
Relative Density:
1.3659 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
2,4-Diamino-6-hydroxypyrimidine can be used in enzyme research to investigate the inhibition of GTP cyclohydrolase I.
Library Information
Target:
NO synthase; GTP cyclohydrolase I
Receptor:
NO synthase; GTP cyclohydrolase I
Pathways:
Immunology/Inflammation; NF-κB signaling; Metabolism
Plate Number:
AOCL-15
Plate Location:
h3
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
60 mg/mL; 475.74 mM
